Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- Check2 days agoChange DetectedA new version (v3.4.1, posted 2026-01-29) adds updates to Study Status and Contacts/Locations plus a government funding notice. The prior version (v3.4.0, 2025-12-24) was deleted.SummaryDifference1%

- Check9 days agoChange DetectedAdded a 'Show glossary' option and introduced green/red color-coded highlights to distinguish additions and deletions. The page updated to display the revision label as v3.4.0 and to include a 'No FEAR Act Data' entry, replacing the previous v3.3.4 entry.SummaryDifference0.8%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe history now shows a new revision entry v3.3.4 and the removal of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedNew history entries dated 2025-12-24 and 2025-12-23 add Study Status and Contacts/Locations. An earlier entry dated 2025-06-13 was removed.SummaryDifference0.4%

- Check45 days agoChange DetectedAdded a new Revision: v3.3.3 entry and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check67 days agoChange DetectedThe latest version shows Revision: v3.3.2 replacing v3.3.1 in the Record History; this is a minor metadata update with no visible changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.